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COCKA YNE'S SYNDROME FIBROBLASTS HAVE INCREASED 
SENSITIVITY TO ULTRAVIOLET LIGHT BUT NORMAL 
RATES OF UNSCHEDULED DNA SYNTHESIS 
ALAN D. ANDREWS, M.D., SUSANNA F. BARRETT, M.A. , FRANK W. YODER, M.D., AND JAY H. ROBBINS, M.D. 
Dermatology Branch, National Cancer Institute, National Institutes of H ealth, Bethesda, Maryland, U.S.A. 
Cockayne's syndrome is a form of cachectic dwarfism 
characterized by acute sun sensitivity and numerous 
other abnormalities of many organ systems. We studied 
fibroblasts from 9 Cockayne's syndrome patients to de-
termine if their fibroblasts had abnormal post-ultravi-
olet light colony-forming ability or abnormal ultraviolet 
light-induced unscheduled DNA synthesis. The fibro-
blast strains from all the patients had markedly de-
creased post-ultraviolet light colony-forming ability in 
comparison with fibroblasts from control donors. Since 
this increased ultraviolet light sensitivity is propagable 
in vitt:o. it may be a manifestation of, or be closely 
associated with, the inherited genetic defect of this 
autosomal recessive disease. However, the patients' fi-
broblasts had normal rates of ultraviolet light-induced 
unscheduled DNA synthesis. Thus, unlike the UV sensi-
tivity of DNA excision repair-deficient xeroderma pig-
mentosum strains, the UV sensitivity of Cockayne's syn-
drome strains is not related to abnormal DNA excision 
repair, at least to the extent that this repair process is 
reflected by rates of ultraviolet light-induced unsched-
uled DNA synthesis. 
Cockayne's syndrome (CS) is a rare autosomal recessive 
disease characterized clinically by acute sun sensitivity, cach-
ectic dwarfism, and multiple progressive neurological abnor-
malities [1-6]. Cultured skin fibroblasts from CS patients have 
been reported by Schmickel and co-workers [7-9] to have 
decreased post-ultraviolet (UV) colony-forming ability (CFA), 
decreased UV-induced unscheduled DNA synthesis (UDS), and 
normal pyrimidine dimer removal. We have studied in vitro 
skin fibroblasts from 9 unrelated CS patients including 2 of the 
patients studied by Schmickel et al [7-9]. We h ave found that 
strains from all the CS patients have decreased post-UV CF A 
but normal rates of UV -induced UDS. 
Manuscript received September 19, 1977; accepted for publication 
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24:624A, 1976). 
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Abbreviations: 
BE: Bethesda 
CFA: colony-forming ability 
CS: Cockayne's syndrome 
S-phase: DNA synthesis-phase 
SD: San Diego 
SE: Seattle 
TO: Toronto 
UDS: unscheduled DNA synthesis 
UV(L) : ultraviolet (light) 
MATERIALS AND METHODS 
Five of the 9 CS fibroblast strains studied, designated GM-739, GM-
955, GM-1098, GM-1629, and GM-1856, were from the Human Genetic 
Mutant Cell Repository, Copewood and Davis Streets, Camden, New 
J ersey 08103. Strains GM-739 and GM-955 were derived from the 2'1l-
yeru·-old and the 4-year-old patients, respectively, of Chu et al [8]. 
Unpublished clinical descriptions of these patients were kindly supplied 
to us by Dr. Roy D. Schmickel, University of Michigan Hospital, Ann 
Arbor, Michigan. Strains GM-1098 [10], GM-1629 (derived from case 
IV of reference 11), and GM-1856 were from patients whom we exam-
ined clinically and whose diagnosis we confirmed [12]. These patients 
ru·e designated CS2BE, CS1BE, and CS3BE, respectively [12]. * Strain 
CSNNSD (derived from case 2 of reference 14) was the gift of Dr. 
Kenneth Lee Jones, University of California School of Medicine, San 
Diego; strain CSNGBE [15] was the gift of Dr. J. E. Seegmiller, and 
was originally derived while he was at the National Institutes of Health, 
Bethesda; strain CSRDSE (available now as GM-1428 at the Human 
Genetic Mutant Cell Repository) was the gift of Dr. George Mru·tin, 
University of Washington School of Medicine, Seattle, Washington, 
and an unpublished clinical descript ion of this patient was kindly 
-supplied to us by Dr. Judith Hall, University of Washington School of 
Medicine, Seattle; and strain CSKCTO (case III of reference 16 and 
patient KC of reference 17) was grown in our laboratory from a biopsy 
obtained by Dr. Robert M. Ehrlich, Hospital for Sick Children, Toronto, 
Canada. The 3 normal control donor fibroblast strains studied, desig-
nated control donors LM (CRL 1224 ), PB (CRL 1121), and A (CRL 
1221) , were from the American T ype Culture Collection, Rockville, 
Maryland. 
All strains were tested for mycoplasma contamination by myco-
plasma culture techniques and by evidence of incorporation of·tritiated 
thymidine into cell-bound mycoplasma by our standard autoradi-
ographic technique [18]. No mycoplasma contamination was found. 
Post-UV CFA was determined as previously described in our studies 
with xeroderma pigmentosum fibroblasts [19] except that the medium 
used in the present work was Ham's Fl2 medium modified according 
to Coon and Weiss [20] and supplemented with 20% fetal calf serum. 
Irradiation was with 254 .nm UVL from a germicidal lamp (G.E. Lamp 
No. G15T8) at an incident flux of0.74 to 0.84 erg/mm2/sec. The colony-
forming efficiency was defined as the number of colonies obtained 
divided by the number of cells plated. Post-UV CF A was calculated by 
dividing the colony-forming efficiency of the irradiated cells at a given 
dose by the colony-forming efficiency of that strain's unirradiated cells 
in the same experiment. A total of 38 experiments were performed, and 
the results for each strain were obtained from 2 to 6 experiments, 
except in the case of strain CSNGBE which was used in only 1 
experiment. 
UV -induced UDS in the first 3 post-irradiation how-s was determined 
as previously described [18]. Such UDS is a reflection of DNA excision 
repair [21]. 
• In partial accordance with an international effort [13] to standard-
ize nomenclature of cell strains from patients with hereditru·y diseases, 
ow- designation of CS1BE will signify both the patient and fibroblast 
strains derived from the patient: CS, Cokayne's syndrome; 1, first 
patient of our CS patient series; BE, for Bethesda, Mru·yland, where 
the patient was examined and characterized clinically. These patients' 
fibroblast strains and/ or Epstein-Barr virus-transformed lymphocyte 
cell lines, identifiable under this standardized nomenclature, are or will 
soon be available from the Human Genetic Mutant Cell Repository. 
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FIG 1. Reduced post-UV CFA of CS fibroblast strains. The long 
exponential portion of the curve for each control donor and CS strain 
was fitted by the method of least squares though all the points along its 
course obtained from several (n) experiments. Control donors: 0, n = 
2; /':. , n = 2; \7, n = 5; Cockayne's syndrome: e, highest CS strain, n = 
3; •. lowest CS strain, n = 5. One point for control donor LM and 4 
points for control donor A above 240 erg/mm2 are not shown. Experi-
mental details in Materials and Methods. 
RESULTS 
Each of the 9 CS strains tested for post-UV CF A was found 
to have an increased sensitivity to UV compared to the normal 
strains .. Figure 1 shows the post-UV CF A for the 3 control 
donor strains used (open symbols) and for the CS strains with 
the highest (e) and with the lowest <•) post-UV CFA. The 
curves given by the 3 control donor strains were similar to those 
given by control donor strains in previous work [19]. There are 
2 components to each control donor's curve: an initial portion, 
which has little if any downward slope and which extends to 
about 25-35 erg/mm2, and a long exponential portion, the slope 
of which has a Dot in the range of 31.1 to 37.1 erg/mm2 • The 
straight lines for the long exponential portions were fitted by 
the method of least squares, and the correlation coefficients 
ranged from 0.96 to 0.99, indicating a good fit between the data 
and the lines. Standard statistical coincidence tests [22] for the 
comparison of 2 lines showed no significant differences (p ::> 
0.10) among the control donors' curves. 
Each of the CS strains gave a post-UV CFA curve which 
differed significantly from the control donor curves (Fig 1). The 
CS curves have initial steep portions, extending to about 10 
erg/mm2, followed by less steep, long exponential portions 
having Dos in the range of 12.6 (•) to 24.0 (e) erg/mm2• Thus, 
the CS strains' post-UV CFA curves have 'negative' shoulders, 
in contrast to the 'positive' shoulders of control donor curves. 
The slopes of the long exponential portions of the CS curves 
differ from those of the control donor curves only slightly in 
certain cases, e.g., 0.05 < p < 0.10 for comparison of slopes 
between the CSNNSD curve and the curve of control donor 
LM, but differ very significantly in other cases, e.g., p < 0.0005 
for comparison of slopes between the GM-739 curve and the 
curve of control donor LM. As is apparent in Fig 1, however, all 
CS curves differ significantly (p < 0.0005) from all control donor 
curves by tests for coincidence [22], indicating that, throughout 
the dose-range tested, all the CS strains had lower post-UV 
CF A than the control donor strains. The curve of the CS strain 
with the highest post-UV CFA (e) differed significantly from 
the curve of the CS strain with the lowest post-UV CF A (•) 
(p < 0.0005). Among the other 7 strains tested, GM-1856 has a 
curve indistinguishable from that of CSNNSD (e), GM-1098 
t The Do value is the UV dose required to reduce the CFA from any 
point on the exponential portion of the curve to 37% of that point. 
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and CSRDSE have curves indistinguishable from that of GM-
739 <•), and the remaining 4 strains have curves between these 
extremes . 
Figure 2 shows the results of UV-induced UDS experiments 
in a control donor strain (Fig 2a) and in 2 CS strains (Fig 2b 
and 2c). The frequency distribution of the number of grains per 
nucleus for the 2 CS strains was similar to that for the control 
donor strain. The average nuclear grain counts (arrows) for the 
control donor and CS cells undergoing UV -induced UDS were 
also similar. Normal rates of liDS were obtained for the other 
7 CS strains studied. 
DISCUSSION 
One of the clinical features of CS is an acute sun sensitivity. 
This clinical feature may be related to the increased UVL 
sensitivity of CS cells demonstrated in our post-UV CF A studies 
on cultured CS skin fibroblasts in vitro. It seems likely, more-
over, that such a sensitivity to UVL may be present in all 
nucleated cells from CS patients. For example, lymphocyte cell 
lines were derived by Epstein-Barr virus transformation of 
peripheral blood lymphocytes from 2 of the CS patients 
(CSKCTO and CS2BE). Trypan-blue exclusion studies, a 
measure of cell viability, showed these CS lymphocyte cell lines 
to have fewer viable cells than control donor lymphocyte cell 
lines at 48 and 72 hr following irradiation with 254 nm UVL 
(Andrews, Hilder, and Robbins, unpublished observations). 
Some patients with xeroderma pigmentosum also have acute 
sun sensitivity. In studies of xeroderma pigmentosum fibro-
blasts' increased sensitivity to 254 nm UVL in post-UV CF A 
experiments [19], we have found that the xeroderma pigmen-
tosum strains with greatest sensitivity to the UVL were from 
patients with histories of acute sun sensitivity reactions. The 
less sensitive strains were from patients who had never experi-
enced such reactions (Andrews, Barrett, and Robbins, in prep-
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FIG 2. Histograms of autoradiographic data showing the frequency 
distribution of the number of grains per nucleus for UV-irradiated 
fibroblasts of a control donor strain (a) and for 2 CS strains (band c) . 
Fifty consecutively observed non-S-phase fibroblasts were evaluated 
on each autoradiogram. The number indicated with an arrow repre-
sents the average nuclear grain count. 
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aration). Thus, in both CS and xeroderma pigmentosum, the 
clinical manifestation of acute sun sensitivity may result from 
the defect which is responsible for the in vitro UV sensitivity of 
the patients' cells. 
The cause of the CS strains' increased sensitivity to UVL is 
not known. The possibility that CS patients have a DNA repair 
defect was first suggested in the reports of Schmickel, Chu, and 
Trosko [7] and Chu et al [8]. They reported that CS cells had 
not only increased sensitivity to UVL in post-UV CF A experi-
ments but also subnormal repair of UV-induced DNA damage 
as evidenced by subnormal levels of UV -induced UDS. How-
ever, we are unable to demonstrate a decreased initial rate of 
UV-induced UDS in any of our CS strains, including the 2 
strains reported by Chu et al [8] to have such a defect. Thus, 
our UDS studies suggest that the DNA excision process in CS 
cells is normal, at least to the extent that this process is reflected 
by initial rates of UV-induced UDS. If, however, the excision 
repair process in CS strains is abnormal, the abnormality could 
be in the fidelity of the UDS, which our assay does not measure, 
or in some step of the excision repair process following the 
insertion of new bases. CS strains may have a defect in some 
other DNA repair process or in a process indirectly affecting 
DNA repair mechanisms. Alternatively, the increased sensitiv-
ity of CS cells to UVL could be unrelated to any DNA repair 
process. Host-cell reactivation studies, similar to those per-
formed using xeroderma pigmentosum cells to reactivate UV-
irradia.ted DNA [23] and DNA viruses [24], are being performed 
with CS cells to determine if, in fact, CS cells have a primary 
defect in DNA repair. 
Most CS patients have numerous abnormalities involving the 
nervous, skeletal, and endocrine systems. To date, the only 
consistent, abnormal, in vitro laboratory finding concerning CS 
patients is the increased UVL sensitivity of their cells mani-
fested by the post-UV CFA and trypan-blue exclusion studies. 
This increased UVL sensitivity is propagable in vitro and, 
therefore, may be a manifestation of, or be closely associated 
with, the inherited genetic defect of this autosomal recessive 
disease. Since there is some heterogeneity among CS patients' 
clinical manifestations [ 4], it is possible that there are different 
forms of CS, each the result of a different mutation in the same 
or different cistrons. In this regard, the significantly different 
degrees of UVL sensitivity among CS strains (Fig 1) could also 
represent different genetic forms of CS. However, the in vivo 
and in vitro heterogeneity among CS patients could also be 
caused by genetic differences at loci other than the one respon-
sil)le for this disease. If post-UV CF A studies on cells from CS 
siblings can be performed, as were conducted on xeroderma 
pigmentosum siblings' cells [19], resolution of this question may 
be possible. 
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